Our Team & Story

 

Our Story. The research project commenced in April 2017 as a result of cooperation between Maria Znamenska (LinkedIn), the owner of the ophthalmic clinic and a Ph.D. in Ophthalmology, and Andrey Kuropyatnyk (LinkedIn), an MBA and IT consultant.

Together they decided to digitalize the world of eye care practice and make one of the most common diagnostic methods, Optical Coherence Tomography (OCT), more efficient.

In April 2018, Altris was among the winners of the Global New Venture Challenge, a global startup competition of the Chicago Booth School of Business.

Also, the company Altris Inc. was incorporated in April 2018. At the moment, Altris Inc. is an ecosystem of products that includes Altris IMS (a web platform for OCT data management with AI models for Research Use Only in the USA) and Altris Education OCT (a free mobile app for OCT education interpretation).

Altris IMS system is already installed in more than 500 + optometry centers and ophthalmic clinics around the world and helps hundreds of optometrists and ophthalmologists. Altris Education OCT is used by 17000+ ophthalmologists and optometrists as an education tool. The number of satisfied customers is growing steadily.

Location. The company is headquartered in Chicago, the USA, with R&D centers located in Kyiv, Ukraine, and Malaga, Spain.

 

Mission: Altris Inc. is setting higher diagnostic standards in OCT interpretation and improving patient outcomes.

Company Milestones

 

• In May 2019 the company signed the first partnership agreement with Huvitz Corporation, a South Korean ophthalmic equipment manufacturer 

• In July 2019, Altris IMS received a CE-mark certificate as medical software 

• In September 2019, the company released Altris IMS participated in EURETINA for the first time

• In May 2020, the company started R&D activities in OCT structural analysis for early retina neurodegeneration detection.

• In September 2021, Altris IMS in partnership with Topcon Healthcare, was implemented in the clinics where Topcon tomographs are installed

• In 2022, the team grew to 30+ members 

        In 2023

• In February 2023, the Altris Team attended a 100% Optical conference in London to discuss the Altris IMS platform and AI in the eye care industry in general

• In the first half of 2023, we were featured in the Ophthalmology Times, Eyes on Eyecase, the Eyewire, the Ophthalmologist, and the New Optometrist, and Optometry Today 

 

• In September 2023 U.S. Food and Drug Administration (FDA) granted 510(k) clearance, Class II, to the Altris Image Management System. For the US clients, AI/ML models are For Research Use Only. Not for use in diagnostic procedures.

 

• In September 2023 our team visited the ESCRS conference to showcase the platform and meet our numerous partners.

 

• In September 2024, Altris IMS partnered with Heidelberg Engineering, and now our system is available on AppWay

 

• In the same September 2024, the Altris IMS team visited Vision Expo West in Las Vegas

 

• In October 2024, we attended the American Academy of Ophthalmology event for the first time, laying the ground in the USA

 

• In March 2025, Maria Znamenska, Chief Medical Officer at Altris IMS, gave a lecture at the Optical Suppliers Association stand during 100% Optical in London

 

• In September 2025, during EURETINA, Altris IMS presented a new feature called Flags for Smart Patient Filtering that allows searching for patient cohorts based on biomarkers and retina pathologies.